149 related articles for article (PubMed ID: 20226014)
21. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
[TBL] [Abstract][Full Text] [Related]
22. Altering PI3K-Akt signalling in zebrafish embryos affects PTEN phosphorylation and gastrulation.
Finkielsztein A; Kelly GM
Biol Cell; 2009 Aug; 101(11):661-78, 4 p following 678. PubMed ID: 19515017
[TBL] [Abstract][Full Text] [Related]
23. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
[TBL] [Abstract][Full Text] [Related]
24. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
25. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Saal LH; Holm K; Maurer M; Memeo L; Su T; Wang X; Yu JS; Malmström PO; Mansukhani M; Enoksson J; Hibshoosh H; Borg A; Parsons R
Cancer Res; 2005 Apr; 65(7):2554-9. PubMed ID: 15805248
[TBL] [Abstract][Full Text] [Related]
26. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
27. Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
Kruger DT; Beelen KJ; Opdam M; Sanders J; van der Noort V; Boven E; Linn SC
Br J Cancer; 2018 Oct; 119(7):832-839. PubMed ID: 30287915
[TBL] [Abstract][Full Text] [Related]
28. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
[TBL] [Abstract][Full Text] [Related]
29. The Akt pathway in human breast cancer: a tissue-array-based analysis.
Bose S; Chandran S; Mirocha JM; Bose N
Mod Pathol; 2006 Feb; 19(2):238-45. PubMed ID: 16341149
[TBL] [Abstract][Full Text] [Related]
30. Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.
Janssen EA; Søiland H; Skaland I; Gudlaugson E; Kjellevold KH; Nysted A; Søreide JA; Baak JP
Cell Oncol; 2007; 29(1):25-35. PubMed ID: 17429139
[TBL] [Abstract][Full Text] [Related]
31. PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.
Carvalho S; Milanezi F; Costa JL; Amendoeira I; Schmitt F
Virchows Arch; 2010 Mar; 456(3):235-43. PubMed ID: 20130907
[TBL] [Abstract][Full Text] [Related]
32. Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer.
Winter JL; Stackhouse BL; Russell GB; Kute TE
Arch Pathol Lab Med; 2007 May; 131(5):767-72. PubMed ID: 17488163
[TBL] [Abstract][Full Text] [Related]
33. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
McBride SM; Perez DA; Polley MY; Vandenberg SR; Smith JS; Zheng S; Lamborn KR; Wiencke JK; Chang SM; Prados MD; Berger MS; Stokoe D; Haas-Kogan DA
J Neurooncol; 2010 Mar; 97(1):33-40. PubMed ID: 19705067
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Significance of Hsp70/Hsp90 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
Dimas DT; Perlepe CD; Sergentanis TN; Misitzis I; Kontzoglou K; Patsouris E; Kouraklis G; Psaltopoulou T; Nonni A
Anticancer Res; 2018 Mar; 38(3):1551-1562. PubMed ID: 29491085
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomic profiling of the PI3K/PTEN pathway in sporadic breast cancer.
Nassiri I; Faghihi M; Tavassoli M
Iran Biomed J; 2009 Apr; 13(2):79-86. PubMed ID: 19471547
[TBL] [Abstract][Full Text] [Related]
36. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PI3K-p110α in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1.
Choi SK; Hong YO; Lee WM; Kim EK; Joo JE; Kim DW; Lee H
Eur J Gynaecol Oncol; 2015; 36(4):389-93. PubMed ID: 26390688
[TBL] [Abstract][Full Text] [Related]
38. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.
Eralp Y; Derin D; Ozluk Y; Yavuz E; Guney N; Saip P; Muslumanoglu M; Igci A; Kücücük S; Dincer M; Aydiner A; Topuz E
Ann Oncol; 2008 Apr; 19(4):669-74. PubMed ID: 18006896
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models.
Shin EJ; Choi HK; Sung MJ; Park JH; Chung MY; Chung S; Hwang JT
Biochem Pharmacol; 2018 Jun; 152():60-70. PubMed ID: 29559312
[TBL] [Abstract][Full Text] [Related]
40. Targeting PTEN-defined breast cancers with a one-two punch.
Maggi LB; Weber JD
Breast Cancer Res; 2015 Apr; 17(1):51. PubMed ID: 25888162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
